A 6-week Study to Evaluate the Safety and Efficacy of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD
Status:
Withdrawn
Trial end date:
2021-04-22
Target enrollment:
Participant gender:
Summary
This 6-week study is to determine if the study drug, Methylphenidate Hydrochloride (HCl)
Extended-Release Chewable Tablets (ERCT), is safe, tolerable and effective when compared to a
sugar pill or placebo in children 4 to 5 years of age with ADHD.